Načítá se...
Risks of budesonide/formoterol for the treatment of stable COPD: a meta-analysis
PURPOSE: The aim of this study was to investigate the comparative risks of budesonide/formoterol, versus placebo or monotherapies, for the treatment of patients with stable COPD. MATERIALS AND METHODS: We undertook a systematic search of the literature in PubMed, Embase, and the Cochrane Central Reg...
Uloženo v:
| Vydáno v: | Int J Chron Obstruct Pulmon Dis |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Dove Medical Press
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6448539/ https://ncbi.nlm.nih.gov/pubmed/31015757 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S192166 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|